Therapeutic Areas

Clinical Development for CNS and Neurological Diseases

Driving successful outcomes for CNS and Neurology trials is challenging

Second, only to Oncology, CNS, and Neurology clinical trials are incredibly complex and complicated to navigate. CNS trials are plagued with high failure rates at or before phase III, and therefore require careful risk mitigation throughout trial design and execution with close regulatory agency collaboration. That is why Veristat has built a team of scientific-minded experts who have supported more than 250 CNS/Neurology projects, including drug, biologic, and diagnostic trials. More than 35% of these treatments are for rare or ultra-rare neurological diseases or disorders.

Driving CNS and Neurology Treatments to Approval

Our diverse trial experience, coupled with our knowledgeable and experienced teams, allows us to confidently handle the most complex trials and patient populations with the attention and focus needed to navigate the neurological disease landscape.

At Veristat, our experienced teams are poised to plan and implement these efforts quickly providing:

Recent Pandemic Experience


project supported for CNS/Neurology Disorders


clinical trials are rare disorders


clinical trials are genetic neurological disorders

Explore Our Recent Neurology Experience

Neurology Indications
Adrenoleukodystrophy Epilepsy Pain & Inflammation
Alzheimer's Disease Friedreich's Ataxia Parkinson's Disease
Amyotrophic lateral sclerosis (ALS) Genetic Abnormalities Pompe Disease
Attention Deficit Disorder (ADD) Hearing Loss Post-Operative Pain
Attention Deficit/Hyperactivity Disorder (ADHD) Insomnia Sanfilippo Syndrome
Autism Spectrum Disorder Limb Girdle Muscular Dystrophy Type 2i (LGMD2i) Schizophrenia
Canavan Disease Lumbar Radiculopathy Sjogren-Larsson Syndrome (SLS)
Cerebral Adrenoleukodystrophy (CALD) Maroteaux-Lamy Syndrome Sleep Apnea/ Sleep Dysfunction
Depression Migraine Stroke
Diabetic Neuropathy Pain Multiple Sclerosis (MS) Spasticity Due to Spinal Cord Injury
Dravet Syndrome Nocturnal Foot and/or Leg Cramps Spinocerebellar Ataxia (SCA)
Duchenne Muscular Dystrophy Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Tardive Syskinesia


Marketing Applications Approval Record

Webinar Presentation

Future Trends on European Regulations on Medicines

Case Study

The Power of Publishing for an Efficient NDA Submission ...